Molecular characterization of thalassemia and hemoglobinopathy in Southeastern China

[1]  Richard Barnett.  Thalassaemia , 2019, The Lancet.

[2]  H. Gharaibeh,et al.  Clinical Burdens of &bgr;-Thalassemia Major in Affected Children , 2018, Journal of pediatric hematology/oncology.

[3]  D. Weatherall,et al.  Thalassaemia , 2018, The Lancet.

[4]  F. Mavilio,et al.  Gene Therapy Approaches to Hemoglobinopathies. , 2017, Hematology/oncology clinics of North America.

[5]  Shaoke Chen,et al.  Prevalence and genetic analysis of α- and β-thalassemia in Baise region, a multi-ethnic region in southern China. , 2017, Gene.

[6]  Yunyan He,et al.  The prevalence of thalassemia in mainland China: evidence from epidemiological surveys , 2017, Scientific Reports.

[7]  Chi-kong Li.  New trend in the epidemiology of thalassaemia. , 2017, Best practice & research. Clinical obstetrics & gynaecology.

[8]  Dongzhi Li,et al.  The Frequency of α-Globin Gene Triplication in a Southern Chinese Population , 2016, Indian Journal of Hematology and Blood Transfusion.

[9]  Dongzhi Li,et al.  Evidence of Selection for the α-Globin Gene Deletions and Triplications in a Southern Chinese Population , 2015, Hemoglobin.

[10]  Dongzhi Li,et al.  Frequencies of HKαα and anti-HKαα Alleles in Chinese Carriers of Silent Deletional α-Thalassemia , 2015, Hemoglobin.

[11]  Dongzhi Li,et al.  Prevention of Hb Bart’s (γ4) Disease Associated with the – –THAI α0-Thalassemia Deletion in Mainland China , 2015, Hemoglobin.

[12]  Li Wu,et al.  High prevalence of thalassemia in migrant populations in Guangdong Province, China , 2014, BMC Public Health.

[13]  Jie Yu,et al.  [Prevalence and molecular analysis of α-thalassemia in preschool children in Chongqing city]. , 2014, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[14]  Li Wu,et al.  The Prevalence and Molecular Spectrum of α- and β-Globin Gene Mutations in 14,332 Families of Guangdong Province, China , 2014, PloS one.

[15]  Y. Li,et al.  Detection of a novel large deletion causing α-thalassemia in South China. , 2013, Experimental and molecular pathology.

[16]  N. Lin,et al.  Molecular Spectrum of β-Thalassemia in Fujian Province, Southeastern China , 2013, Hemoglobin.

[17]  Hailong Huang,et al.  [Molecular epidemiological analysis of α- and β-thalassemia in Fujian province]. , 2013, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[18]  Lei Zheng,et al.  Hemoglobinopathy: Molecular Epidemiological Characteristics and Health Effects on Hakka People in the Meizhou Region, Southern China , 2013, PloS one.

[19]  A. Canataroğlu,et al.  β-Globin chain abnormalities with coexisting α-thalassemia mutations , 2012, Archives of medical science : AMS.

[20]  S. Zeinali,et al.  The Carrier Frequency of α-Globin Gene Triplication in an Iranian Population with Normal or Borderline Hematological Parameters , 2011, Hemoglobin.

[21]  Ke Chen,et al.  Molecular Spectrum of α- and β-Globin Gene Mutations Detected in the Population of Guangxi Zhuang Autonomous Region, People's Republic of China , 2011, Hemoglobin.

[22]  Raffaella Origa,et al.  BETA THALASSEMIA , 2018, The Professional Medical Journal.

[23]  Huang Guo-zhi.  Molecular epidemiology survey of α-thalassemia in Zhongshan city , 2010 .

[24]  Li Yuquan,et al.  Epidemiological survey of α-thalassemia in population of Shunde area in Guangdong Province. , 2009 .

[25]  Yuan Yiping.  Molecular and clinical characteristics of β-thalassemia in guangdong province , 2008 .

[26]  Shaoqing Wu,et al.  Prenatal Diagnosis of β-Thalassemia by Reverse Dot-Blot Hybridization in Southern China , 2006, Hemoglobin.

[27]  Zhou Dai-feng.  INVESTIGATION OF SIX TYPES β-THALASSEMIA MUTATION IN HAN NATIONALITY OF HAINAN PROVINCE , 2005 .

[28]  S. Schrier,et al.  New strategies in the treatment of the thalassemias. , 2005, Annual review of medicine.

[29]  G. Luo,et al.  The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening , 2004, Journal of Clinical Pathology.

[30]  Y. Li,et al.  The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. , 2004, Journal of clinical pathology.

[31]  W. Erber,et al.  Single-Tube Multiplex-PCR Screen for Anti-3.7 and Anti-4.2 α-Globin Gene Triplications , 2003 .

[32]  V. Viprakasit,et al.  Allele related mutation specific-polymerase chain reaction for rapid diagnosis of Hb New York (beta 113 (G15) Val-->Glu, beta(CD113 GTG-->GAG)). , 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[33]  Xiang-min Xu,et al.  Evaluation of clinical application of gap-PCR as a routine method for alpha-thalassemia carrier detection. , 2002, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[34]  D. Higgs,et al.  The −−THAI and −−FIL determinants of α thalassemia in Taiwan , 1999, American journal of hematology.

[35]  Y. Nishioka,et al.  Deletional -Thalassemia with High HB A 2 , 1988 .

[36]  B. Popovich,et al.  Deletional beta-thalassemia with high Hb A2. , 1988, Hemoglobin.

[37]  S. Antonarakis,et al.  Beta-thalassemia in China: a systematic molecular characterization of beta-thalassemia mutations. , 1988, Hemoglobin.

[38]  S. Na-nakorn,et al.  Haemoglobin J‐Bangkok: A Clinical, Haematological and Genetical Study , 1967, British journal of haematology.